Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   94663 News 


«12...1314151617181920212223...10631064»
  • ||||||||||  methylprednisolone acetate / Generic mfg.
    Bullous Pemphigoid: A Case Report of a 15-Month-Old Female Infant (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2524;    
    The patient was treated with ketotifen suspension and 0.1 % methylprednisolone acetate cream twice daily... Bullous pemphigoid should be considered in the differential diagnosis of bullous lesions observed during infancy.
  • ||||||||||  Erdotin (erdosteine) / Recipharm, Alitair Pharma, Daewoong Pharma
    Improvement of Severe Scleroderma Cases with Lung and Heart Involvement Treated Using Methotrexat (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2506;    
    However, in the observations on patients for 1 month after therapy showed improvement of the condition of skin stiffness and reduced shortness of breath. MTX accompanied by systemic corticosteroids can be an inexpensive treatment option even in severe scleroderma conditions.
  • ||||||||||  Difficulties in diagnosing the erosive-ulcerative form of vulvar lichen sclerosis. (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2500;    
    In most cases, the average time from symptom onset to diagnosis is 3-5 years, during which time patients receive inappropriate, ineffective treatment and symptoms progress. There are rare descriptions of the erosive-ulcerative form of lichen sclerosis in the literature.
  • ||||||||||  Unusual presentation of pemphigus vegetans (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2496;    
    The patient was treated with oral prednisolone 0.5 mg/kg, azathioprine 100 mg daily, and topical clobetasol propionate ointment. Unlike
  • ||||||||||  Humira (adalimumab) / AbbVie
    A rare case of recalcitrant Pemphigus vulgaris with co-existing Behcet (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2489;    
    A strong pathergy phenomenon, poor response to high-dose oral and intravenous steroids and HLA*B51 positivity pointed towards a co-existing BD which is an extremely rare association and may be resistant to multiple immunosuppressants. A high degree of suspicion is required in any case of recalcitrant pemphigus vulgaris to rule out a coexisting or an independently existing BD.
  • ||||||||||  dapsone / Generic mfg., prednisolone / Generic mfg.
    Infantile Bullous Pemphigoid: A Case Report (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2469;    
    Our comprehensive evaluation, which includes pathological confirmation, and therapeutic interventions, enhances our understanding of IBP. The case underscores the necessity for prompt diagnosis and individualized treatment strategies in affected infants.
  • ||||||||||  Dupixent (dupilumab) / Sanofi, Regeneron
    Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2247;    
    It is possible that Th2 pathway inhibition by dupilumab may promote Demodex proliferation, which could lead to increased IL- 17-mediated inflammation. Rosacea disease is dominated by TH1/Th17 cells, often accompanied by infiltration of macrophages and mast cells4 In our case, systemic therapy with an IL-13 inhibitor could be continued without worsening of the skin reaction.
  • ||||||||||  propylthiouracil / Generic mfg.
    Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in a patient with hyperthyroidism: a case report (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2109;    
    The concomitant conditions of the patient included arterial hypertension treated with methylprolol succinat 50 mg daily, hyperthyroidism treated with propylthiouracil 50 mg two tablets two times per day (she had the treatment for two years) , diabetes type two treated with metformin hydrochloride 500 mg, two tablets per day...The patient was treated with intravenous dexamethasone, 12 mg for the initial 6 days and 16 mg for the consecutive 7 days, esomeprazole 40 mg once daily for 6 days, and local clobetasol propionate cream... The physicians should be aware of the possibility for the development of ANCA-associated vasculitis as an adverse effect of propylthiouracil treatment for hyperthyroidism.
  • ||||||||||  prednisolone / Generic mfg., diphenhydramine / Generic mfg.
    Durian Hypersensitivity presenting with Acute Angioedema and Urticaria (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2045;    
    The physicians should be aware of the possibility for the development of ANCA-associated vasculitis as an adverse effect of propylthiouracil treatment for hyperthyroidism. She was treated at our hospital
  • ||||||||||  A case of iatrogenic kaposi (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2030;    
    The patient was recieving oral prednisone 60 mg daily in combination with colchicine 1 mg daily since 2019...Oral prednisolone was stopped and immediately switched to oral hydrocortisone... Kaposi
  • ||||||||||  dexamethasone / Generic mfg.
    Erythema multiple major due to TD vaccine (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2024;    
    The vital clues to diagnosis continue to be the clinical history and clinical findings. In this case report, the lesion presents with clinical manifestations that affect the skin and mucosa, especially the perioral region.
  • ||||||||||  meropenem / Generic mfg.
    An unexpected reaction to meropenem: A clinical challenge (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_2011;    
    Materials & A 56-year-old patient received intravenous vancomycin and meropenem for meningitis...Parenteral dexamethasone was initiated, resulting in a widespread desquamation within 13 days...GPFE has been essentially linked to hydroxychloroquine... Our patient
  • ||||||||||  voriconazole / Generic mfg.
    Voriconazole and Lentigines: a Little-Known Side Effect (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1973;    
    Discussion Although these lesions are initially benign, it is important to note that there are reports in the medical literature of cases where voriconazole-induced lentigines may undergo malignant transformation, increasing the risk of developing squamous cell carcinoma and malignant melanoma, especially in transplantation patients. It is important for patients on voriconazole therapy to be regularly monitored for the appearance of new skin lesions and to be advised to avoid excessive sun exposure and to use adequate sun protection.
  • ||||||||||  celecoxib oral / Generic mfg.
    Drug-induced Lupus secondary to celecoxib: an unusual presentation as a papular rash. (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1956;    
    A 46-year-old female patient presented to the dermatology department with a pruritic eruption lasting for 10 days, which recurred after receiving intravenous methylprednisolone in the emergency department. Celecoxib is an uncommon cause of drug-induced lupus, with only one case of similar clinical presentation in the literature.
  • ||||||||||  Xefo (lornoxicam) - Old API Wind / down, Takeda
    Drug induced Fuchs Syndrome - A novel case report (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1940;    
    This condition is under- diagnosed as well as under-reported probably due to multiple terminologies involved and thus causing diagnostic confusion. Considering it to be EM major can avoid such controversy.
  • ||||||||||  doxycycline / Generic mfg.
    Doxycycline induced generalized morbilliform rash simulating viral exanthem. (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1939;    
    To differentiate between its two most common causes (drug-induced and viral) , most often remains a diagnostic challenge. History, clinical, and histopathological findings may help to arrive at the correct diagnosis but are usually inadequate in distinguishing between these two.
  • ||||||||||  cetirizine oral / Generic mfg., prednisolone / Generic mfg.
    A case of terbinafine induced photoallergy (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1934;    
    This case reiterates the importance of awareness of this rare complication. This case also raises the possibility that the topically applied terbinafine may have exacerbated the photosensitive rash as this patient noted significant improvement in areas not exposed to the sun with application of topical terbinafine but had no symptomic improvement in the rash in areas exposed to the sun, even prior to the commencement of the oral terbinafine.
  • ||||||||||  An uncommon case of follicular occlusion triad with challenging treatment outcome: a case report (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1729;    
    Despite advancements in therapy, management remains unsatisfactory compared to the treatment of individual components. This case highlights the incidence of this uncommon syndrome and the need for more research into therapeutic options specifically tailored to address FOT and its associated comorbidities, aiming to improve patient outcomes and quality of life.
  • ||||||||||  triamcinolone acetonide / Generic mfg.
     (Poster Area) -  Aug 5, 2024 - Abstract #EADV2024EADV_1672;    
    Co2 laser ablation combined with intralesional triamcinolone can be an effective treatment option in AKN.Both these procedures are carried out by most dermatosurgeons individually but combining them in the same sitting is a novel approach that has helped us optimize the results. Resolution of plaques and nodules with good cosmetic appearance, no relapse, and almost no downtime was seen in our patients with this simple outpatient procedure
  • ||||||||||  Tarpeyo (budesonide) / Calliditas, Stada
    Review, Journal, Immunomodulating:  Insights on Nefecon (Pubmed Central) -  Aug 5, 2024   
    These studies demonstrated that Nefecon has a distinct pharmacokinetic profile from other budesonide products, allowing for targeted, localized action in the distal ileum. When considered alongside existing clinical trial data showing the effect of Nefecon on gut-associated biomarkers, available evidence indicates that Nefecon has a selective immunomodulatory mechanism of action and a direct disease-modifying effect in patients with IgAN, while having low systemic exposure and adverse effects.
  • ||||||||||  hydrocortisone / Generic mfg.
    Journal:  Hydrocortisone treatment as a tool to study conjunctival placode induction. (Pubmed Central) -  Aug 4, 2024   
    Hydrocortisone treatment reduces Fgf20 expression independently of ?-catenin and Eda and may instead affect other members of the Wnt/?-catenin or Eda/Edar pathways, or it may affect the ability of morphogens to diffuse through the extracellular matrix. This study contributes to a growing profile of gene expression data during placode development and enhances our understanding of how some vertebrate eyes develop these fascinating bones.